AbbVie says Congress excluded Botox from price controls Lawsuit alleges multiple constitutional violations Botox contributes over 10% to AbbVie's annual revenue HHS declines to comment Feb 12 (Reuters ...
AbbVie has sued the Department of Health and Human Services (HHS), challenging the agency’s decision to select its blockbuster anti-wrinkle therapy Botox for the next round of Medicare price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results